Ergoteles’s Clarivate CLVT Stock Holding History

Ergoteles’s Portfolio CLVT Stock Details CLVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-27,878	Closed	-$266K	–	196
2023 Q2	$266K	Buy	+27,878	New	+$236K	0.01%	793

Other funds holding CLVT

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

Exor N.V. Amsterdam, Netherlands $5.38B AUM 6.22% 1-Year Est. Return

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Ergoteles's CLVT Position: Q3 2023 in Review

Ergoteles sold out of Clarivate (CLVT) in Q3 2023, closing a stake of 27,878 shares — an estimated $266K sold.

Ergoteles first reported a position in CLVT in Q2 2023 and held it in 1 quarter. The position peaked at $266K in Q2 2023. 241 funds tracked by Wall St. Rank hold CLVT as of Q3 2023.

Ergoteles reported no remaining Clarivate position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 27,878 Clarivate shares in Q3 2023, an estimated $266K.
Ergoteles first reported a position in Clarivate in Q2 2023 and held it in 1 quarter.
Ergoteles's Clarivate position peaked at $266K in Q2 2023.
241 funds tracked by Wall St. Rank held Clarivate as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.